News

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...
Digital health company Noom has launched a compound pharmacy-made version of Novo Nordisk's obesity drug semaglutide to make the drug more accessible to consumers in the US. The bold move has been ...
Washington D.C: US President Donald Trump has unveiled a new luxury fragrance collection titled “Victory 45-47”, symbolising ...
This morning, the Danish pharmaceutical giant Novo Nordisk announced the abrupt end of its brief partnership with telehealth ...
Mobile apps bypass Apple's 30% fee with web payments. Case studies show up to 190% revenue increases using proven frameworks.
Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.
NORTHAMPTON, MA / ACCESS Newswire / June 24, 2025 /Originally published in GoDaddy's 2024 Sustainability Report Employee ...
Makeda, 33, shed four stone after learning to manage her busy lifestyle, which sees her juggling three children - including ...
Novo Nordisk cut ties with Hims & Hers, accusing the telehealth firm of promoting Wegovy copycat versions of the weight-loss ...
Building and marketing a mobile app is hard; turning that hard work into profit is even harder. Until recently, developers unwilling to surrender up to 30 ...